Aclaris Therapeutics 10K 2023 Annual report | ACRS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accessible, accidental, accomplished, Addendum, adenocarcinoma, adenosine, adware, agenda, AI, allegedly, alleviate, analyzed, androgenetic, assembled, assumption, ATP, attack, attendant, authentication, automated, background, bad, bankruptcy, biannually, billion, binding, biochemical, biochemistry, biology, biomarker, bond, catalytic, CCPA, cellular, Chapter, chemotherapy, clearing, Colorado, comment, conflict, Connecticut, conservative, contemporary, contrast, CPRA, credential, culled, cybersecurity, cysteine, deceptive, deep, degradation, delete, delisted, delisting, deploying, destroy, destruction, deuruxolitinib, devoid, ductal, Dysregulation, elaborate, email, encryption, engine, environment, enzymology, exhibit, exhibiting, exploited, Extortion, fake, FIRINOX, Florida, FOLFIRINOX, forensic, fraction, frequency, GDPR, gene, genetic, genome, glue, halting, hard, hardware, harvesting, home, honor, hosted, hundred, idea, immunology, inactive, infer, input, inquiry, intelligence, Interagency, Irinotecan, irreversible, isotopic, killing, kinome, KPPC, library, machinery, main, manual, MBC, metabolite, mice, microenvironment, mid, misrepresentative, misuse, modification, molecular, multicomponent, multidisciplinary, murine, network, Novan, offline, online, organizational, osteoclast, PDAC, persistent, petition, phishing, Phosphorylated, phosphorylation, physiological, physiologically, poor, QD, quickly, RANKL, regular, relocate, remedial, remediate, resistance, retaliatory, ruxolitinib, SBDD, scaffolding, Secretary, segregation, server, signalosome, silico, steady, sterling, streamline, stromal, stuffing, subscribing, subset, sue, Sun, talented, team, theft, thirteen, tissue, transduction, triphosphate, trough, tumor, UK, undermine, unfair, unique, unlawful, upregulated, Virginia, Washington, wave, whichever, wiretapping, young

Removed: apportioned, assume, attempted, Auxilium, bowel, Bristol, Bryan, Chesterbrook, Clarifying, cloud, cohort, commitment, computing, conventional, costimulatory, CPK, creatine, damage, deficiency, dispensed, disruption, durable, electrical, elevated, evolution, focusing, headache, hsCRP, hydroxychloroquine, implicit, inappropriate, infection, inhibit, injectable, intensity, interaction, intrusion, investigative, invoiced, Johnson, joining, landlord, leased, leflunomide, Lincoln, long, LP, Mallinckrodt, marked, master, median, methotrexate, monoclonal, movement, muscle, nondeductible, nonsteroidal, oversee, pandemic, Park, pathogenic, phosphokinase, plc, predicted, prepaid, prohibited, projected, regulator, reproduce, Rigel, Roche, secondary, solution, sophistication, Squibb, stimulated, strain, Sublandlord, sublicense, subsequently, sulfasalazine, synthetic, telecommunication, terminal, therapy, TNF, tract, updated, urinary, UTI, vaccination, ventricular, withdrew

Aclaris Therapeutics (ACRS) 10-K2023 FY Annual report

Content analysis